Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Change in Accured Expenses (2024 - 2025)

BioAge Labs (BIOA) has disclosed Change in Accured Expenses for 2 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 38.71% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.4 million through Dec 2025, down 173.73% year-over-year, with the annual reading at -$3.4 million for FY2025, 173.73% down from the prior year.
  • Change in Accured Expenses hit $1.4 million in Q4 2025 for BioAge Labs, up from -$542000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $8.2 million in Q3 2024 to a low of -$6.9 million in Q1 2025.